CompletedNCT01804699
National ARVC Data Registry and Bio Bank
Studying Inherited arrhythmogenic cardiomyopathy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of British Columbia
- Principal Investigator
- Andrew D Krahn, MDUniversity of British Columbia, Dept of Medicine, Head of Cardiology
- Enrollment
- 1500 target
- Eligibility
- 2 years · All sexes
- Timeline
- 2013 – 2020
Study locations (16)
- Libin Cardiovascular Institute of Alberta, University of Calgary, Calgary, Alberta, Canada
- BC Children's Hospital, Vancouver, British Columbia, Canada
- University of British Columbia, St. Paul's Hospital, Vancouver, British Columbia, Canada
- University of Victoria, Victoria Jubilee Hospital, Victoria, British Columbia, Canada
- St. Boniface Hospital, Winnipeg, Manitoba, Canada
- Queen Elizabeth II, Halifax Infirmary, Halifax, Nova Scotia, Canada
- McMaster University, Faculty of Health Sciences, Hamilton, Ontario, Canada
- Lawson Health Research Institute, London, Ontario, Canada
- Ottawa Heart Institute, Ottawa, Ontario, Canada
- St. Michael's Hospital, Toronto, Ontario, Canada
- The Hospital for Sick Children, Toronto, Ontario, Canada
- Toronto General Hospital, Toronto, Ontario, Canada
- McGill University Health Centre, Montreal, Quebec, Canada
- Montreal Heart Institute, Montreal, Quebec, Canada
- St. Justine Hospital, Montreal, Quebec, Canada
- +1 more locations on ClinicalTrials.gov
Collaborators
Population Health Research Institute · Medtronic · Boston Scientific Corporation · Canadian Institutes of Health Research (CIHR)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01804699 on ClinicalTrials.govOther trials for Inherited arrhythmogenic cardiomyopathy
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT06922994Statin Effect on Arrhythmogenic Cardiomyopathy Disease Progression (SEARCH)Centro Cardiologico Monzino
- RECRUITINGNCT06352307Risk Stratification, Early Prevention and Treatment Strategies for Arrhythmogenic CardiomyopathyFirst Affiliated Hospital Xi'an Jiaotong University
- RECRUITINGNCT06976606A Study to Assess Real-world Patient Characteristics and Clinical Course for Symptomatic Patients With PKP2-ACMLexeo Therapeutics
- RECRUITINGPHASE1NCT05885412A Phase 1, Dose Escalation Trial of RP-A601 in Subjects With PKP2 Variant-Mediated Arrhythmogenic Cardiomyopathy (PKP2-ACM)Rocket Pharmaceuticals Inc.
- RECRUITINGNANCT06040242Arrhythmogenic Activity During Exercise in ARVC PatientsSwiss Federal Institute of Technology
- RECRUITINGNCT06409585Cardiomyopathies and Heart Muscle Diseases: Cardiac Imaging in the Evaluation of Myocardial Fibrosis TransitionUniversity of Edinburgh
- RECRUITINGNANCT06311708Non-interventional Study of Seroprevalence of Pre-existing Antibodies Against Adenovirus-associated Virus Vector (AAV9) and the Progression of Disease in Patients With Plakophilin 2 (PKP2)-Associated Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)Tenaya Therapeutics
- RECRUITINGNCT04521790Role of Endomyocardial Biopsy and Aetiology-based Treatment in Patients With Inflammatory Heart Disease in Arrhythmic and Non-arrhythmic Clinical Presentations: an Integrated Approach for the Optimal Diagnostic and Therapeutic ManagementScientific Institute San Raffaele
See all trials for Inherited arrhythmogenic cardiomyopathy →